iA Global Asset Management Inc. Takes Position in Encompass Health Corporation $EHC

iA Global Asset Management Inc. purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC) in the second quarter, according to its most recent 13F filing with the SEC. The fund purchased 59,841 shares of the company’s stock, valued at approximately $7,338,000. iA Global Asset Management Inc. owned approximately 0.06% of Encompass Health at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. GHP Investment Advisors Inc. lifted its holdings in shares of Encompass Health by 2.3% during the 2nd quarter. GHP Investment Advisors Inc. now owns 19,035 shares of the company’s stock worth $2,334,000 after acquiring an additional 434 shares during the last quarter. Amalgamated Bank lifted its holdings in shares of Encompass Health by 1.5% during the 2nd quarter. Amalgamated Bank now owns 46,786 shares of the company’s stock worth $5,737,000 after acquiring an additional 671 shares during the last quarter. Keybank National Association OH lifted its holdings in shares of Encompass Health by 36.7% during the 2nd quarter. Keybank National Association OH now owns 12,683 shares of the company’s stock worth $1,555,000 after acquiring an additional 3,407 shares during the last quarter. Hantz Financial Services Inc. lifted its holdings in shares of Encompass Health by 16,653.8% during the 2nd quarter. Hantz Financial Services Inc. now owns 76,900 shares of the company’s stock worth $9,430,000 after acquiring an additional 76,441 shares during the last quarter. Finally, Whalen Wealth Management Inc. bought a new stake in shares of Encompass Health during the 2nd quarter worth $644,000. 97.25% of the stock is owned by institutional investors.

Insider Activity

In related news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the transaction, the executive vice president owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.00% of the company’s stock.

Encompass Health Stock Performance

Encompass Health stock opened at $113.86 on Monday. The firm has a fifty day simple moving average of $124.22 and a two-hundred day simple moving average of $119.10. Encompass Health Corporation has a twelve month low of $87.85 and a twelve month high of $127.99. The company has a market capitalization of $11.47 billion, a PE ratio of 21.52, a P/E/G ratio of 2.20 and a beta of 0.93. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The firm had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s payout ratio is presently 14.37%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on EHC shares. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 21st. Truist Financial lifted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a report on Thursday, August 14th. UBS Group lifted their price objective on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Weiss Ratings reissued a “buy (b+)” rating on shares of Encompass Health in a research note on Wednesday, October 8th. Finally, Barclays boosted their price target on shares of Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday. Two research analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.